Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.71 USD | -1.26% | +4.93% | +124.43% |
04-29 | Stoke Therapeutics Appoints Thomas Leggett CFO | MT |
04-29 | Stoke Therapeutics, Inc. Announces Executive Changes, Effective May 7, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.43% | 618M | |
+1.52% | 42.86B | |
+12.17% | 42.74B | |
+44.81% | 41.36B | |
-8.83% | 27.68B | |
+7.70% | 25.15B | |
-23.18% | 18.63B | |
+30.22% | 12.37B | |
-2.72% | 11.92B | |
+7.39% | 11.21B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Correction: Stoke Therapeutics Reports Data From Observational Study of Patients With Dravet Syndrome